Tzvi Palash
2011
In 2011, Tzvi Palash earned a total compensation of $649K as Chief Operating Officer at Protalix BioTherapeutics, a 114% increase compared to previous year.
Compensation breakdown
| Option Awards | $339,011 |
|---|---|
| Salary | $233,452 |
| Other | $76,490 |
| Total | $648,953 |
Palash received $339K in option awards, accounting for 52% of the total pay in 2011.
Palash also received $233.5K in salary and $76.5K in other compensation.
Rankings
In 2011, Tzvi Palash's compensation ranked 7,222nd out of 10,747 executives tracked by ExecPay. In other words, Palash earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,222 out of 10,747 | 33rd |
Division Manufacturing | 2,634 out of 3,960 | 34th |
Major group Chemicals And Allied Products | 637 out of 1,038 | 39th |
Industry group Drugs | 440 out of 786 | 44th |
Industry Biological Products, Except Diagnostic Substances | 73 out of 162 | 55th |
Source: SEC filing on October 9, 2014.
Palash's colleagues
We found four more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2011.
2011
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2011
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2011
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2011
Einat Almon
Protalix BioTherapeutics